RAFAEL HOLDINGS, INC. Accounts Payable and Other Accrued Liabilities, Current
RAFAEL HOLDINGS, INC. (RFL) had Accounts Payable and Other Accrued Liabilities, Current of $3.90 million as of 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2026-06-11
- 2026-04-30: Accounts Payable and Other Accrued Liabilities, Current $3.90M.
- 2026-01-31: Accounts Payable and Other Accrued Liabilities, Current $400.00K.
- 2025-07-31: Accounts Payable and Other Accrued Liabilities, Current $3.60M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current |
|---|---|
| 2026-04-30 | $3.90M 10-Q · filed 2026-06-11 |
| 2026-01-31 | $400.00K 10-Q · filed 2026-03-16 |
| 2025-07-31 | $3.60M 10-Q · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |